Raymond James Financial
NVAX icon

Raymond James Financial’s Novavax NVAX Stock Holding History

Raymond James Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$746K Buy
91,634
+7,564
+9% +$68.6K ﹤0.01% 4074
2025
Q4 		$565K Sell
84,070
-3,436
-4% -$25.9K ﹤0.01% 4175
2025
Q3 		$759K Sell
87,506
-34,738
-28% -$270K ﹤0.01% 3860
2025
Q2 		$770K Buy
122,244
+60,438
+98% +$400K ﹤0.01% 3739
2025
Q1 		$396K Sell
61,806
-5,838
-9% -$48.3K ﹤0.01% 4069
2024
Q4 		$544K Buy
+67,644
New +$652K ﹤0.01% 3855

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's NVAX Position: Q1 2026 in Review

Raymond James Financial increased its Novavax (NVAX) stake by 9% in Q1 2026, buying an estimated $68.6K and bringing the position to 91,634 shares worth $746K. The position accounts for ﹤0.01% of the portfolio, ranked #4074.

Raymond James Financial first reported a position in NVAX in Q4 2024 and has held it in 6 quarters since. The position peaked at $770K in Q2 2025. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Raymond James Financial held 91,634 shares of Novavax worth $746K as of Q1 2026.
  • Raymond James Financial bought 7,564 Novavax shares in Q1 2026, an estimated $68.6K.
  • Novavax made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4074 holding.
  • Raymond James Financial first reported a position in Novavax in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Novavax position peaked at $770K in Q2 2025.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.